Arsenic exposure assists ccm3 genetic polymorphism in elevating blood pressure

Area of Science:

• Environmental Health
• Genetics
• Cardiovascular Epidemiology

Background:

• Epidemiologic studies suggest a link between arsenic exposure and increased blood pressure.
• The precise mechanisms, particularly gene-environment interactions, remain incompletely understood.

Purpose of the Study:

• To investigate the combined effects of arsenic exposure and CCM3 gene polymorphisms on blood pressure elevation.
• To identify specific CCM3 gene variants that interact with arsenic exposure to influence hypertension risk.

Main Methods:

• A study involving 395 Chinese individuals.
• Utilized multiple logistic regression models to analyze associations and interactions.
• Adjusted for confounding factors including age, gender, lifestyle, and education.

Main Results:

• Serum arsenic levels positively correlated with blood pressure, cholesterol, glucose, and C-reactive protein.
• Arsenic exposure increased the risk of elevated systolic and diastolic pressure (ORs 1.725 and 1.425).
• Specific CCM3 gene variant interactions (e.g., rs3804610*rs9818496) significantly elevated SBP risk, with combined arsenic exposure further increasing this hazard.

Conclusions:

• Arsenic exposure, in conjunction with specific CCM3 gene polymorphisms, contributes to the elevation of systolic blood pressure.
• Findings underscore the importance of considering both environmental exposures and genetic factors in hypertension etiology.